Cargando…

Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells

Limited therapeutic options are available for advanced-stage hepatocellular carcinoma owing to its poor diagnosis. Drug resistance to sorafenib, the only available targeted agent, is commonly reported. The comprehensive elucidation of the mechanisms underlying sorafenib resistance may thus aid in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chih-Ta, Liao, Li-Zhu, Lu, Ching-Hui, Huang, Yung-Hsuan, Lin, Yu-Kie, Lin, Jung-Hsin, Chow, Lu-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156679/ https://www.ncbi.nlm.nih.gov/pubmed/32203105 http://dx.doi.org/10.1038/s12276-020-0404-2

Ejemplares similares

Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020)

EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
por: Gajdzis, Malgorzata, et al.
Publicado: (2020)

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors
por: Hatano, Manabu, et al.
Publicado: (2004)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
por: Charmsaz, Sara, et al.
Publicado: (2015)

Y772 phosphorylation of EphA2 is responsible for EphA2-dependent NPC nasopharyngeal carcinoma growth by Shp2/Erk-1/2 signaling pathway
por: Xiang, Yi-Ping, et al.
Publicado: (2020)

Roles of EphA2 in Development and Disease
por: Park, Jeong Eun, et al.
Publicado: (2013)

The EphA1 and EphA2 Signaling Modulates the Epithelial Permeability in Human Sinonasal Epithelial Cells and the Rhinovirus Infection Induces Epithelial Barrier Dysfunction via EphA2 Receptor Signaling
por: Shin, Jae Min, et al.
Publicado: (2023)

Modulation of EphA7 and pEphA7 Protein Expression: Potential Biomarkers for Early Detection of Hepatocellular Carcinoma
por: Priya, Shivani, et al.
Publicado: (2022)

EphA2 bears plasticity to tumor invasion
por: Sugiyama, Nami, et al.
Publicado: (2013)

SORLA attenuates EphA4 signaling and amyloid β–induced neurodegeneration
por: Huang, Timothy Y., et al.
Publicado: (2017)

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model
por: Bhatia, Shilpa, et al.
Publicado: (2015)

Protein kinase A can block EphA2 receptor–mediated cell repulsion by increasing EphA2 S897 phosphorylation
por: Barquilla, Antonio, et al.
Publicado: (2016)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
por: Murakoshi, Maki, et al.
Publicado: (2022)

A Novel Occulta-Type Spina Bifida Mediated by Murine Double Heterozygotes EphA2 and EphA4 Receptor Tyrosine Kinases
por: Abdullah, Nor Linda, et al.
Publicado: (2017)

EphA2 and EGFR: Friends in Life, Partners in Crime. Can EphA2 Be a Predictive Biomarker of Response to Anti-EGFR Agents?
por: Cioce, Mario, et al.
Publicado: (2021)

TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma
por: Lai, Hui‐Huang, et al.
Publicado: (2019)

EphA3 Functions are Regulated by Collaborating Phosphotyrosine Residues
por: Shi, Guanfang, et al.
Publicado: (2010)

EphA4 is a prognostic factor in gastric cancer
por: Miyazaki, Kohji, et al.
Publicado: (2013)

Unliganded EphA3 dimerization promoted by the SAM domain
por: Singh, Deo R., et al.
Publicado: (2015)

Identification and characterization of Nanobodies targeting the EphA4 receptor
por: Schoonaert, Lies, et al.
Publicado: (2017)

Oncogenic Functions and Therapeutic Targeting of EphA2 in Cancer
por: Wilson, Kalin, et al.
Publicado: (2021)

miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2
por: Jin, Qiao, et al.
Publicado: (2016)

Differential Roles for EphA and EphB Signaling in Segregation and Patterning of Central Vestibulocochlear Nerve Projections
por: Allen-Sharpley, Michelle R., et al.
Publicado: (2013)

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery
por: Stammes, Marieke A., et al.
Publicado: (2017)

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
por: Cui, Shuang, et al.
Publicado: (2021)

Novel [(111)In]In-BnDTPA-EphA2-230-1 Antibody for Single-Photon Emission Computed Tomography Imaging Tracer Targeting of EphA2
por: Furukawa, Takenori, et al.
Publicado: (2023)

Evidence That the EphA2 Receptor Exacerbates Ischemic Brain Injury
por: Thundyil, John, et al.
Publicado: (2013)

Structures of the EphA2 Receptor at the Membrane: Role of Lipid Interactions
por: Chavent, Matthieu, et al.
Publicado: (2016)

Downregulation of EphA5 by promoter methylation in human prostate cancer
por: Li, Shibao, et al.
Publicado: (2015)

EphA2 is a functional receptor for the growth factor progranulin
por: Neill, Thomas, et al.
Publicado: (2016)

Progranulin and the receptor tyrosine kinase EphA2, partners in crime?
por: Chitramuthu, Babykumari, et al.
Publicado: (2016)

EphA8 is a prognostic marker for epithelial ovarian cancer
por: Liu, Xiaoqin, et al.
Publicado: (2016)

EphA2 cleavage helps tumor cells go it alone
por: Short, Ben
Publicado: (2013)

Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
por: Yi, Zhongzhen, et al.
Publicado: (2018)

Theoretical Model of EphA2-Ephrin A1 Inhibition
por: Jedwabny, Wiktoria, et al.
Publicado: (2018)

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
por: Offenhäuser, Carolin, et al.
Publicado: (2018)

A role of the SAM domain in EphA2 receptor activation
por: Shi, Xiaojun, et al.
Publicado: (2017)

EphA7 isoforms differentially regulate cortical dendrite development
por: Leonard, Carrie E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qdr8pknqvi9nrcl1f8ak59f0lt